Using RECIST criteria for tumor progression and disease response, the mean change in CEA for patients with progression was an increase in 19 ng/mL, compared to a change of –7.3 ng/mL in those with ...

Improving the AJCC/TNM staging for adenocarcinomas of the appendix: The prognostic impact of histologic grade. Background: The objective of the present investigation was to assess whether elevated pre ...

Background: The usefulness of tumor markers in NSCLC is not well defined. High levels of CEA are considered a negative prognostic factor in early-stages NSCLC but its role in advanced disease is yet ...